Posted in | News | Medical Robotics

Clinical Use of Accuray's CyberKnife Robotic Radiosurgery Systems to be Presented at AAPM Meeting

Accuray declared that during the 54th Annual Meeting of the American Association of Physicists in Medicine (AAPM), over 70 studies based on the clinical application of the TomoTherapy System and the CyberKnife Robotic Radiosurgery System will be presented. With 4,000 attendees, this AAPM event is being held from July 29 to August 2, 2012 at Charlotte, N.C.

Presentations on CyberKnife System as well as TomoTherapy System continue to confirm Accuray's accurate patient setup and intrafraction motion tracking, and standard-setting treatment planning and delivery techniques. In addition, the quality assurance methods for the industry's foremost, fully-integrated radiosurgery and intensity-modulated radiotherapy platforms will also be validated through the presentation.

The presentations will also highlight clinical applications such as the unique capability of TomoTherapy System to create dose homogeneity and organ sparing in hippocampal-avoidance whole brain radiotherapy. In addition, the exceptional ability of CyberKnife System to provide a stable tracking precision while treating liver tumors experiencing a large degree of respiratory motion will be demonstrated.

During the symposium on July 30, 2012 at The Westin Charlotte Hotel, Accuray will accentuate its new VoLO technology for the TomoTherapy System. This novel treatment planning platform is based on a new dose calculation algorithm and modern parallel processing technology for maximum clinical efficiency, throughput and versatility in creating complicating treatment plans.

TomoTherapy's new Dose Control System capable of enhancing system stability while and between treatments will also be demonstrated at the event.

The TomoTherapy System uses daily computed tomography (CT) imaging and a radiation beam rotating in 360 degree arcs, and serves to be a fully integrated 3D image guided intensity modulated radiation therapy system for treating cancers. The CyberKnife System is the first, unique robotic radiosurgery system ensuring cancer patients with a pain-free, non-invasive treatment procedure.

Source: http://www.accuray.com/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Accuray Incorporated. (2019, February 20). Clinical Use of Accuray's CyberKnife Robotic Radiosurgery Systems to be Presented at AAPM Meeting. AZoRobotics. Retrieved on May 02, 2024 from https://www.azorobotics.com/News.aspx?newsID=3054.

  • MLA

    Accuray Incorporated. "Clinical Use of Accuray's CyberKnife Robotic Radiosurgery Systems to be Presented at AAPM Meeting". AZoRobotics. 02 May 2024. <https://www.azorobotics.com/News.aspx?newsID=3054>.

  • Chicago

    Accuray Incorporated. "Clinical Use of Accuray's CyberKnife Robotic Radiosurgery Systems to be Presented at AAPM Meeting". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3054. (accessed May 02, 2024).

  • Harvard

    Accuray Incorporated. 2019. Clinical Use of Accuray's CyberKnife Robotic Radiosurgery Systems to be Presented at AAPM Meeting. AZoRobotics, viewed 02 May 2024, https://www.azorobotics.com/News.aspx?newsID=3054.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.